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Edited by Hans-Dieter KlenkAbstract Kaposis sarcoma-associated herpesvirus replication
transcriptional activator (Rta) plays a critical role in the switch
from latency to lytic replication. Rta upregulates several lytic
KSHV genes, including its own, through multiple mechanisms.
We demonstrate that cellular HMGB1 binds and synergistically
upregulates the ORF50 promoter in conjunction with Rta. No di-
rect interaction between Rta and HMGB1 was observed, how-
ever a ternary complex is formed in the presence of Oct1.
Furthermore, deletion of an Oct-1 binding site within the
ORF50 promoter ablates the HMGB1-mediated synergistic re-
sponse. These results suggest Rta autostimulation may be medi-
ated by a transient complex involving Oct1 and HMGB1.
 2008 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Kaposis sarcoma-associated herpesvirus (KSHV) is the eti-
ological agent of several of AIDS-related malignancies includ-
ing Kaposis Sarcoma [1,2]. In common with all herpesviruses
KSHV has two distinct phases within its life cycle latency and
lytic replication. The KSHV ORF50 gene product known as
the replication and transcriptional activator (Rta) is con-
served within all gamma-2 herpesviruses and plays a critical
role in the switch from latency to lytic replication [3–5].
Expression of Rta in KSHV-latently infected cells is necessary
and suﬃcient to induce lytic replication [6]. Rta initiates lytic
replication through transcriptional activation of a variety of
lytic genes [7–11] via direct binding to promoter DNA se-
quences or through interactions with cellular transcriptional
control proteins including RBP-Jj [12] C/EBPa [13] AP1 [14]
and HMGB1 [15].
The high mobility (HMG) protein HMGB1, is an abundant
nuclear non-histone chromatin-associated protein. HMGB1 is
composed of three domains consisting of two tandem box do-
mains (A and B boxes) and an acidic carboxy-terminus. Both*Corresponding author. Address: Institute of Molecular and Cellular
Biology, Faculty of Biological Sciences, University of Leeds, Leeds
LS2 9JT, United Kingdom. Fax: +44 (0) 113 3435638.
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doi:10.1016/j.febslet.2008.07.055HMG boxes share a common three-dimensional structure
which can bind DNA through the minor groove resulting in
DNA bending [16,17]. This bending of DNA creates a favour-
able DNA conﬁrmation allowing the binding of other proteins
to DNA. HMGB1 has been shown to enhance the binding of a
variety of sequence-speciﬁc DNA-binding proteins including
p53, Hox domain proteins and octamer binding factors
(Oct1/2) [18]. HMGB1 has also been shown to stimulate both
Epstein Barr virus (EBV) lytic transactivating proteins, Rta
and ZEBRA [19,20]. Interestingly, stimulation of these two
proteins is via two distinct methods. HMGB1 binds DNA in
a sequence-speciﬁc manner to promote the HMGB1 and ZE-
BRA nucleoprotein complex. Conversely, HMGB1 has no se-
quence speciﬁcity or direct protein–protein interaction when
promoting EBV Rta binding to DNA.
Recent analysis has shown that HMGB1 can upregulate
Rta-mediated transactivation by enhancing Rta binding to a
range of KSHV lytic promoters [15]. Rta has also been shown
to autostimulate its own promoter [21,22]. Therefore herein,
we determined whether HMGB1 has a role in the autostimula-
tion of the ORF50 promoter.2. Materials and methods
2.1. Cell culture, plasmids and transfection
293T cells were cultured in DMEM supplemented with 10% FCS,
glutamine, and penicillin–streptomycin (Invitrogen). The ORF50 pro-
moter and Rta expression constructs [23] and HMGB1 constructs
[15] have been previously described. pET-HMGB1 was produced by
PCR ampliﬁcation and cloning of the HMG boxes into pET-21b. Plas-
mid transfections were performed using Lipofectamine 2000 (Invitro-
gen), a maximum of 1 lg of each DNA was used per transfection in
a maximum total of 3 lg per combination transfection as per the man-
ufacturers instructions.
2.2. Luciferase assays
Cells were harvested 48 h post-transfection and lysed with passive ly-
sis buﬀer (PLB) (Promega), following the manufacturers instructions.
The luciferase activity of the lysates was determined using LUCII re-
agent (Promega) according to the manufacturers protocol using a Lu-
mat LB 9507 luminometer (EG&G Berthold, Germany).
2.3. Chromatin immunoprecipitation (ChIP) assays
Cell lysates were harvested and ChIP assays performed using the
ChIP assay kit (Upstate Biotechnology). Chromatin extracts, cross-
linking, sonication, immunoprecipitation, agarose bead elution and
protein removal were carried out based on the manufacturers proto-
col. DNA recovered from immunoprecipitates with the appropriateblished by Elsevier B.V. All rights reserved.
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ers to the ORF50 promoter (5 0-CAAAGAGCTTGGGGGGGCAGA-
3 0 and 5 0-TGCCACCCAGCTACTGGTTTC-3 0).
2.4. In vitro pulldown assays
Recombinant His-tagged HMGB1 was expressed and immobilised
to Ni-NTA agarose beads as previously described [24]. Protein expres-
sion of Rta and Oct-1 was performed by in vitro transcription/transla-
tion using the TNT system (Promega) according to the manufacturers
instructions.0
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Fig. 1. HMGB1 and Rta synergistically upregulate the ORF50
promoter. 293T cells were transfected with (a) pORF50D6 or (b)
pORF50D7–9 in the presence of pGFP, pHMGB1 and pRta-GFP as
indicated. Cells were harvested 48 h post-transfection and cell lysates
were assayed for luciferase activity. The variations between three
replicated assays are indicated and data are presented as fold activation
versus empty vector control.
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Fig. 2. HMGB1 associates with the ORF50 promoter. PCR ampliﬁcation
antibody immunoprecipitates using cell extracts transfected with the pGFP,3. Results
3.1. HMGB1 and KSHV Rta synergistically upregulate the
ORF50 promoter
To determine whether HMGB1 has a role in the autostimula-
tion of the ORF50 promoter, 293T cells were transfected with
pORF50D6 (which contains an ORF50 promoter fragment
encompassing 568 bp upstream of the transcription start site
cloned upstream of the luciferase reporter gene [23]) in the ab-
sence or presence of pHMGB1 and/or pRta-GFP. Cells were
harvested 48 h post-transfection and the protein concentration
of each sample calculated. An equal amount of cell extract was
then assayed for luciferase activity. Moreover, to conﬁrm an
equal transfection eﬃciency, immunoﬂuorescence was under-
taken to ensure a comparable number of cells (approximately
60%) were transfected (data not shown). Results showed that
HMGB1 alone had little eﬀect on the ORF50 promoter,
whereas autostimulation was observed in the presence of Rta,
as previously described [21,22]. However, in the presence of
both HMGB1 and Rta a dramatic synergistic response was ob-
served (Fig. 1a). This suggests that HMGB1 enhances the Rta-
mediated autostimulation of the ORF50 promoter, encompass-
ing a promoter region of 568 bp. It must be noted that this was
the largest deletion construct tested in this assay.
To map the HMGB1 responsive regions within the ORF50
promoter, a series of promoter deletions, pORF50D7–9 were
utilised [23]. 293T cells were transfected with each construct
in the absence or presence of pHMGB1 and/or pRta-GFP
and assayed for luciferase activity as described above. A syner-
gistic response in the presence of both Rta and HMGB1 was
observed using pORF50D7 and pORF50D8. However, this
stimulatory response was lost between D8 and D9 constructs
(Fig. 1b). This suggests the region required by HMGB1 and
Rta to synergistically activate the ORF50 promoter is located
within the 128 bp between D8 and D9, comprising 71299–
71427 bp of the published sequence [1].
3.2. HMGB1 associates with the ORF50 promoter
To determine whether the synergistic response on the ORF50
promoter in the presence of HMGB1 and Rta is through direct
interactions of HMGB1 with the ORF50 promoter, chromatin
immunoprecipitation (ChIP) assays were performed. 293T cells
were transfected with pORF50D6 in the absence or presence of
either pHMGB1 and/or pRta-GFP. After 24 h, the cells were
harvested and chromatin extracts, cross-linking, sonication,
immunoprecipitation, agarose bead elution andprotein removalORF50
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HMGB1- or GFP-speciﬁc antibodies were then used as tem-
plates to speciﬁcally amplify theORF50 promoter. Results dem-
onstrate that HMGB1 can associate with the ORF50 promoter
in both the absence andpresence ofRta (Fig. 2).Moreover,ChiP
analysis demonstrates a positive interaction between endoge-
nous HMGB1 and the ORF50 promoter in GFP-transfected
cells. These results suggest that the synergistic response is possi-
bly due to the HMGB1 protein binding the ORF50 promoter.Rta
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Fig. 3. Oct-1 binding to the ORF50 promoter is required for the
HMGB1/Rta synergistic response. (a) Ni-NTA bead bound HMGB1
or beads alone were incubated with 35S-Met-labelled Oct-1, Rta or
empty vector control produced by ITT. Following washes, bound
proteins were separated by SDS–PAGE and the dried gel was exposed
to autoradiograph ﬁlm for 16 h. (b) PCR ampliﬁcation of the ORF50
promoter from HMGB1-speciﬁc or no antibody immunoprecipitates
using cell extracts transfected with the pGFP, pHMGB1 and/or pRta-
GFP in the presence of pORF50DOct. (c) 293T cells were co-
transfected with (a) pORF50D6 or (b) pORF50DOct in the presence
of pGFP, pHMGB1 and pRta-GFP as indicated. Cells were harvested
48 h post-transfection and cell lysates were assayed for luciferase
activity. The variations between three replicated assays are indicated
and data are presented as fold activation versus empty vector control.3.3. Oct-1 binding to the ORF50 promoter is required for the
HMGB1/Rta synergistic response
The deletion analysis experiments shown inFig. 1b highlight a
region within the ORF50 promoter required for the HMGB1/
Rta synergistic response. This region encompasses an Oct-1
binding site, essential for Rta-mediated autostimulation [25].
Interestingly, the HMG boxes of HMGB1 and 2 proteins have
been shown to stimulate the bindingof sequence-speciﬁc binding
proteins, including Oct-1, in vitro. Moreover, Rta has been
shown to directly interact with Oct-1 and this interaction is crit-
ical for transactivation of lytic promoters [26]. Therefore, we
tested whether a multi-protein complex is formed comprising
HMGB1,Oct-1 andRta and also assessed the direct interactions
between these proteins. Pulldown experiments were performed
using the recombinant histidine-tagged HMGB1 protein immo-
bilised to beads and incubating with radio-labelled Oct-1 or Rta
proteins.Results showed thatOct-1 bounddirectly to the recom-
binant HMG boxes, in contrast no direct interaction was ob-
served between HMGB1 and Rta (Fig. 3a). However, upon
repeating the pulldown, incubatingHMGB1 protein in the pres-
ence of both radiolabelled Oct-1 or Rta a ternary complex was
observed (Fig. 3a). This suggests that Oct-1 may function as a
bridge between HMGB1 and Rta to facilitate assembly of an
enhanceosome.
To further investigate the role of this multi-protein complex
on the activation of the ORF50 promoter, we assessed what ef-
fect mutating the Oct-1 binding site within the ORF50 pro-
moter would have on the synergistic activation by HMGB1/
Rta. A mutant ORF50 promoter construct upstream of the
luciferase reporter gene, pORF50-DOct, was therefore gener-
ated by site-directed mutagenesis which prevented the binding
of Oct-1 as previously described [25]. ChIPs assays were then
performed to assess whether HMGB1 could still bind with
the ORF50 promoter-lacking the Oct-1 binding site. Results
showed that HMGB1 can still associate with the ORF50 pro-
moter in the absence of Oct-1 (Fig. 3b).
The ability of HMGB1/Rta to synergistically activate the
ORF50 promoter in the absence of Oct-1 was then assessed.
293T cells were transfected with pORF50-DOct in the absence
or presence of pHMGB1 and/or pRta-GFP. Cell extracts were
then assayed for luciferase activity. A decrease in autostimula-
tion of the pORF50-DOct promoter construct in the presence
of Rta was observed compared to the wild type promoter, as
previously observed [25]. However, no synergistic response
was observed in the presence of Rta and HMGB1 using the
ORF50 promoter construct lacking the Oct-1 binding site
(Fig. 3c). Therefore, even the presence of endogenous or over-
expressed HMGB1 has limited eﬀect on the ORF50 promoter
in the absence of Oct-1 and suggests that Oct-1 binding is re-
quired by HMGB1 and Rta to synergistically activate the
ORF50 promoter.The latent-lytic switch is essential for KSHV virion propaga-
tion and has critical implications in disease pathogenesis [2].
KSHV Rta is the key regulator of the latent-lytic switch, thus
the regulation of the ORF50 promoter and Rtas ability to aut-
ostimulate is key to lytic reactivation. Herein, we have demon-
strated that HMGB1 augments Rta-mediated autostimulation
of the ORF50 promoter. HMGB1 has previously been shown
to enhance the ability of Rta to bind DNA to four diﬀerent
S.M. Harrison, A. Whitehouse / FEBS Letters 582 (2008) 3080–3084 3083Rta-responsive sequences, thus leading to their transactiva-
tion. Results herein suggest that HMGB1 can also interact
with the ORF50 promoter suggesting that HMGB1 has little
sequence speciﬁcity and is consistent within the hypothesis that
HMGB1 probably recognises DNA structure rather than se-
quence [18]. In an attempt to identify any sequence speciﬁcity
of HMGB1 we utilised a deletion series of the ORF50 pro-
moter and analysis suggested that the synergistic response ob-
served was lost upon deletion of the Oct-1 binding site within
the ORF50 promoter. Further analysis to assess a possible role
of Oct-1 in HMGB1-mediated activation identiﬁed a possible
direct interaction between HMGB1 and Oct-1. It has previ-
ously been shown that HMG proteins can functionally interact
with the POU domains of Oct factors [27]. Moreover, analysis
suggests that Oct-1 may also interact with Rta to form a ter-
nary complex with HMGB1. However, we believe this ternary
complex may be transient, as we have been unable to detect a
HMGB1/Oct-1/DNA or HMGB1/Rta/DNA complexes with
suﬃcient stability to assay using EMSAs (data not shown).
It will be of interest to determine whether this synergistic re-
sponse and complex formation exists in primary eﬀusion lym-
phomas and what eﬀect mutating the Oct-1 binding site with
the ORF50 promoter has in the context of the wild type virus.
Interestingly, recent analysis has shown that the Oct-1/Rta
interaction is critical for regulating KSHV reactivation [26].
Furthermore, Oct-1 binding to the lytic K-bZIP promoter
stimulates Rta DNA binding and also augments Rta-mediated
transactivation. At present, however, the mechanism of this
stimulation is unknown. It will also be interesting to determine
whether HMGB1 has any role to play in enhancing the Oct-1/
Rta augmentation of this and other KSHV lytic promoters.
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